DJIA 17,689.86 -56.12 -0.32%
NASDAQ 5,128.28 -0.50 -0.01%
S&P 500 2,103.84 -4.79 -0.23%
market minute promo

MannKind Corp (NASDAQ: MNKD)

4.29 -0.17 (-3.81%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MNKD $4.29 -3.81%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.34
Previous Close $4.46
Daily Range $4.25 - $4.47
52-Week Range $3.46 - $10.08
Market Cap $1.8B
P/E Ratio -9.91
Dividend (Yield) $0.00 (0.0%)
Volume 4,103,877
Average Daily Volume 5,283,058
Current FY EPS -$0.31




Drug Makers

MannKind Corp (MNKD) Description

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer. Website:

News & Commentary

3 Stocks that Are Fool's Gold

These stocks hold big potential to make you a millionaire, but they are also extremely high risk. Our group of experts think you should stay away from these 3 stocks.

MannKind Triples Production Capacity for Afrezza

Why MannKind Corp. Stock Briefly Dropped Today

MannKind's shares briefly dipped by double-digits today. Here's why.

MannKind Afrezza Sales Underwhelming Again, Sanofi Reports

Why MannKind Corp.'s Stock Slumped Today

MannKind's stock fell by almost 10% today. Here's why.

MannKind Relies on 'Death Spiral' Financing to Help Settle Looming Debt

MannKind's Afrezza May Reach Larger Diabetic Population Than Previously Considered

MannKind Continues To Decline

Biotech Stocks Falling Broadly, Here's Why And How Much

MannKind Investors See Long-Term Success With Afrezza

See More MNKD News...

MNKD's Top Competitors

MNKD $4.29 (-3.81%)
Current stock: MNKD
AMGN $176.59 (2.85%)
Current stock: AMGN
GILD $117.86 (-0.03%)
Current stock: GILD
BIIB $318.78 (0.56%)
Current stock: BIIB